JP2011047715A - Method for detecting cancer based on comprehensive analysis of mineral components in hair - Google Patents
Method for detecting cancer based on comprehensive analysis of mineral components in hair Download PDFInfo
- Publication number
- JP2011047715A JP2011047715A JP2009194688A JP2009194688A JP2011047715A JP 2011047715 A JP2011047715 A JP 2011047715A JP 2009194688 A JP2009194688 A JP 2009194688A JP 2009194688 A JP2009194688 A JP 2009194688A JP 2011047715 A JP2011047715 A JP 2011047715A
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- value
- hair
- mineral
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
Description
本発明は毛髪中ミネラル成分の網羅的分析に基づく癌の検出方法等に関する。 The present invention relates to a cancer detection method based on comprehensive analysis of mineral components in hair.
癌は先進国において死亡の第一原因であり、毎年一千万人以上の新たな癌患者が見出されている。これまでに、癌の潜在危険因子を同定するために関する実証的及び疫学的な研究報告が数多くなされており、その中には、カドミウム、ニッケル、ベリリウム又はヒ素等の発癌性金属に関する研究がある(非特許文献1〜4)。
Cancer is the leading cause of death in developed countries, and more than 10 million new cancer patients are found each year. To date, there have been many empirical and epidemiological research reports on identifying potential risk factors for cancer, including research on carcinogenic metals such as cadmium, nickel, beryllium or arsenic ( Non-patent
しかしながら、これまでに、発癌の危険性と複数の生体ミネラル成分との関連に関する網羅的な詳細解析研究はなされていない。 However, exhaustive detailed analysis studies on the relationship between the risk of carcinogenesis and a plurality of biological mineral components have not been made so far.
本発明者等は、これまでに数多くの検体に関して毛髪中のミネラル成分を網羅的に分析し、それらの値と様々な肉体的又は精神的疾患との関連について解析・研究してきた(非特許文献5〜7)。例えば、毛髪中のミネラルと肥満度や癌リスクとの関係を多変量解析した結果から、数種類のミネラル濃度と肥満度や癌リスクとの間に正又は負の相関がみられることを見出した(非特許文献7,8及び9)。
The inventors of the present invention have comprehensively analyzed mineral components in hair for a large number of specimens, and have analyzed and studied the relationship between these values and various physical or mental disorders (Non-Patent Documents). 5-7). For example, from the results of multivariate analysis of the relationship between minerals in hair and the degree of obesity and cancer risk, it was found that there is a positive or negative correlation between the concentration of several minerals and the degree of obesity and cancer risk ( Non-patent
そこで、本発明の目的は、頭髪中の複数のミネラル成分量に基づく癌の新たな検出方法等を提供することである。 Accordingly, an object of the present invention is to provide a new method for detecting cancer based on the amount of a plurality of mineral components in hair.
上述した目的を達成するため、本発明者らが鋭意検討した結果、多重ロジスティック回帰分析を用いた詳細な統計学的解析によって、癌、特に固形癌の有無と、頭髪中の必須及び有害ミネラルを含む複数のミネラル成分濃度が統計学的に有意に相関することを見出し、それに基づき本発明を完成するに至った。 As a result of intensive studies by the present inventors in order to achieve the above-mentioned object, by detailed statistical analysis using multiple logistic regression analysis, the presence or absence of cancer, particularly solid cancer, and essential and harmful minerals in hair are determined. The present inventors have found that a plurality of mineral component concentrations to be included are statistically significantly correlated, and based on this, the present invention has been completed.
すなわち、本発明は以下の各態様を包含する。 That is, the present invention includes the following aspects.
[態様1]
被験者の毛髪中のミネラル成分濃度を測定し、得られた測定値と被験者の年齢及び性別を指標として癌を検出する方法。
[態様2]
被験者の毛髪中のミネラル成分濃度を測定し、得られた測定値と被験者の年齢及び性別から統計的解析によって、統計学的に有意な変化を与える値を得、その値に基づき癌を検出する、態様1記載の方法。
[態様3]
統計的解析として、多重ロジスティック回帰分析を用いる、態様1又は2記載の方法。
[Aspect 1]
A method of measuring cancer by measuring a mineral component concentration in a subject's hair and using the obtained measured value and the age and sex of the subject as indices.
[Aspect 2]
Measure the mineral component concentration in the subject's hair, obtain a value that gives a statistically significant change from the measured value obtained and the age and sex of the subject, and detect cancer based on that value A method according to
[Aspect 3]
The method according to
本発明方法により、頭髪中の微量ミネラル成分の網羅的な超微量分析という、極めて非侵襲的な超微量分析手段によって、癌、特に固形癌を約84%の高い精度(正確度)で検出することが可能となり、癌を発見・診断し、又は、癌患者をスクリーニングすることができる。 According to the method of the present invention, cancer, particularly solid cancer, is detected with a high accuracy (accuracy) of about 84% by a very non-invasive ultra-trace analysis means of comprehensive trace trace analysis of trace mineral components in hair. It is possible to detect and diagnose cancer or to screen cancer patients.
以下、本発明の最良の実施形態について詳細に説明するが、本発明は当業者に自明のその他の多くの異なる形態による実施が可能であり、本発明の技術的範囲は以下に説明する実施形態及び実施例の記載に限定されるものではない。 BEST MODE FOR CARRYING OUT THE INVENTION The best embodiment of the present invention will be described in detail below, but the present invention can be implemented in many other different forms obvious to those skilled in the art. And it is not limited to description of an Example.
本発明方法で検体として使用する被験者の生体サンプルは毛髪であり、被験者から極めて非侵襲的な手段で取得することができる。量としては約0.1-0.3 gあれば十分であり、本発明方法の精度を確保するためには、出来るだけ頭皮に近い根元から採取した部分(長さ2−3cm程度)を使用することが好ましい。 The biological sample of the subject used as the specimen in the method of the present invention is hair, and can be obtained from the subject by extremely noninvasive means. About 0.1-0.3 g is sufficient as the amount, and in order to ensure the accuracy of the method of the present invention, it is preferable to use a portion (about 2-3 cm in length) collected from the root as close as possible to the scalp. .
毛髪検体中のミネラル成分量(濃度)の測定は当業者に公知の任意の方法で行うことができる。好ましくは、本明細書の実施例に記載したように、洗浄処理後、アルカリ又は硝酸等を使用する適当な溶解処理を経た後に、誘導結合プラズマ質量分析機を用いて測定することが好ましい。 Measurement of the amount (concentration) of mineral components in the hair sample can be performed by any method known to those skilled in the art. Preferably, as described in the examples of the present specification, it is preferable to perform measurement using an inductively coupled plasma mass spectrometer after performing a suitable dissolution treatment using alkali or nitric acid after the washing treatment.
本発明方法では、被験者の毛髪中ミネラル成分濃度の測定値と被験者の年齢及び性別から、適当な統計的解析によって統計学的に有意な変化を与える値を得、その値に基づき癌を検出する。統計的解析の一例として、例えば、多重ロジスティック回帰分析や重回帰分析を挙げることができる。各検体について多重直線回帰により得られた値と癌リスクとの多重ロジスティック回帰分析における相関を用いることが好ましい。ミネラル成分には必須ミネラル及び有害ミネラルが含まれる。又、癌リスクと正の相関が高いミネラル成分、及び、癌リスクと負の相関が高いミネラル成分の夫々数種類を含むことが好ましく、特に、ヨウ素、ヒ素、亜鉛、鉄、ナトリウム、セレン、カリウム、及びマンガン8種類のミネラル濃度を使用することが好ましい。 In the method of the present invention, a value giving a statistically significant change is obtained by appropriate statistical analysis from the measured value of the mineral component concentration in the hair of the subject and the age and sex of the subject, and cancer is detected based on the value. . Examples of statistical analysis include, for example, multiple logistic regression analysis and multiple regression analysis. It is preferable to use the correlation in the multiple logistic regression analysis between the value obtained by multiple linear regression and the cancer risk for each specimen. Mineral components include essential minerals and harmful minerals. In addition, it is preferable to include several kinds of mineral components having a high positive correlation with cancer risk and mineral components having a high negative correlation with cancer risk, in particular, iodine, arsenic, zinc, iron, sodium, selenium, potassium, And it is preferable to use 8 mineral concentrations of manganese.
特に、多重直線回帰に以下の式(1):
多重直線回帰(値)=+0.70 (男性の場合:(+)、女性の場合(−)) + 0.023 x年齢 + 1.75 x LogI+3.59 x LogAs++5.38 x LogZn+6.67 x LogFe+2.04 x LogNa−6.47 x LogSe−1.48 x LogK−1.47 x LogMn−50.88、
を用いることが好ましい。
In particular, the following equation (1) for multiple linear regression:
Multiple linear regression (value) = + 0.70 (for men: (+), for women (-)) + 0.023 x age + 1.75 x LogI + 3.59 x LogAs + + 5.38 x LogZn + 6.67 x LogFe + 2.04 x LogNa- 6.47 x LogSe-1.48 x LogK-1.47 x LogMn-50.88,
Is preferably used.
検出の対象である癌の種類・原発部位等に特に制限はない。 There are no particular restrictions on the type or primary site of cancer that is the object of detection.
上記の適当な統計的解析によって得られる、統計学的に有意な変化を与える値として、「カットオフ値」を挙げることができる。「カットオフ値」は、特定の疾患の検出を目的として設定する値である。かかる「カットオフ値」は当業者に公知の手段で設定することが可能である。例えば、上記の多重直線回帰式(1)により得られた値と癌リスクとの多重ロジスティック回帰分析における相関に基づき、市販の統計解析ソフトを使用してROC(Receiver Operating Characteristic)曲線を作成し、最適な感度及び特異度を求め、検出の目的に応じて、例えば、一次スクリーニング等の目的の検査では感度が高い方を優先し、精査目的の検査では特異度が高くなるようなカットオフ値を設定することが可能である。 As a value giving a statistically significant change obtained by the appropriate statistical analysis described above, a “cutoff value” can be mentioned. The “cut-off value” is a value set for the purpose of detecting a specific disease. Such a “cut-off value” can be set by means known to those skilled in the art. For example, based on the correlation in the multiple logistic regression analysis between the value obtained by the multiple linear regression equation (1) and the cancer risk, a ROC (Receiver Operating Characteristic) curve is created using commercially available statistical analysis software, Find the optimum sensitivity and specificity, and for the purpose of detection, for example, give priority to the higher sensitivity in the inspection for the purpose of primary screening, etc., and set the cut-off value that increases the specificity in the inspection for inspection purposes. It is possible to set.
素問八王子クリニックで癌治療を受けている124名の患者(乳癌:28例、胃癌:22例、肺癌:11例、大腸癌:10例、前立腺癌:9例、肝臓癌:7例、膵臓癌:5例、子宮癌:5例、卵巣癌:4例、食道癌:4例、悪性リンパ腫:4例、腎臓癌:3例、及び、甲状腺癌:2例を含む)の癌患者(男性52名:平均年齢60.9 + 12.2、女性:72名:平均年齢54.9 + 10.6)から、インフォームド・コンセントに基づき、毛髪検体(約0.2 g)を入手し、更に、対照検体として東京都内に住む20−80歳の健常人86名(男性53名:平均年齢51.6 + 11.9、女性:33名:平均年齢53.7 + 16.0)から同様に毛髪検体を入手した。 124 patients undergoing cancer treatment at Hakuoji Clinic (28 breast cancer, 22 stomach cancer, 11 lung cancer, 10 colon cancer, 9 prostate cancer, 9 prostate cancer, 7 liver cancer, pancreas Cancer patients (including male): 5 cases, uterine cancer: 5 cases, ovarian cancer: 4 cases, esophageal cancer: 4 cases, malignant lymphoma: 4 cases, kidney cancer: 3 cases, and thyroid cancer: 2 cases Based on informed consent, hair samples (approximately 0.2 g) were obtained from 52 people: average age 60.9 + 12.2, women: 72 people: average age 54.9 + 10.6), and also live in Tokyo as a control sample Hair samples were obtained in the same manner from 86 healthy people aged 20-80 (53 men: average age 51.6 + 11.9, women: 33: average age 53.7 + 16.0).
毛髪検体(75 mg)を精秤して、プラスチック容器(50 ml)に入れ、毛髪分析標準委員会推薦の洗浄操作(Cranton EM, et al., Standardization and interpretation of human hair for elemental concentrations. J. Holistic Med. 1982;4:10-20)に従い、アセトンで洗浄した後、トライトン溶液(0.01 %)で洗浄した。 A hair sample (75 mg) is precisely weighed and placed in a plastic container (50 ml), and the washing operation recommended by the Hair Analysis Standards Committee (Cranton EM, et al., Standardization and interpretation of human hair for elemental concentrations. According to Holistic Med. 1982; 4: 10-20), it was washed with acetone and then with a Triton solution (0.01%).
洗浄した毛髪検体を10 mlの6.25%水酸化テトラメチルアンモニウム(多摩化学、日本)及び50μlの0.1% 金溶液(SPEX Certi Prep.)と混合し、撹拌しながら75℃で2時間溶解させた。室温まで冷却後、内部標準(Sc, Ga 及びIn)溶液を添加し、その重量を調整して、得られた溶液を測定に使用した。ミネラル濃度の測定は、誘導結合プラズマ質量分析機(ICP-MS;Agilent-7500ce)を用いて国際標準に基づき実施し(Yasuda H, et al., Anti-Aging Med., 2007;4:38-42)、その濃度をng/g(毛髪)で示した。尚、ミネラル分析における品質管理の目的で、国立環境研究所から提供されるヒト頭髪環境標準試料(NIES CRM No.13)を使用した(Yoshinaga J., et al., Fresenius J. Anal. Chem., 1997;357:279-83)。 The washed hair sample was mixed with 10 ml of 6.25% tetramethylammonium hydroxide (Tama Chemical, Japan) and 50 μl of 0.1% gold solution (SPEX Certi Prep.) And dissolved at 75 ° C. for 2 hours with stirring. After cooling to room temperature, an internal standard (Sc, Ga and In) solution was added, the weight was adjusted, and the resulting solution was used for measurement. The mineral concentration was measured based on international standards using an inductively coupled plasma mass spectrometer (ICP-MS; Agilent-7500ce) (Yasuda H, et al., Anti-Aging Med., 2007; 4: 38- 42), the concentration was expressed in ng / g (hair). For the purpose of quality control in mineral analysis, a human hair environment standard sample (NIES CRM No. 13) provided by the National Institute for Environmental Studies was used (Yoshinaga J., et al., Fresenius J. Anal. Chem. 1997; 357: 279-83).
毛髪中のミネラル成分濃度は対数正規分布しているので、毛髪中ミネラル濃度の代表値として相乗(幾何)平均値を用いた。統計学的解析にはミネラル成分濃度の対数値を使用した。24種類のミネラル成分と癌リスクとの関係を多重ロジスティック回帰分析(JMP6; SAS Institute)によって解析した。その結果を表1に示す。 Since the mineral component concentration in the hair has a logarithmic normal distribution, a synergistic (geometric) average value is used as a representative value of the mineral concentration in the hair. Logarithmic values of mineral component concentrations were used for statistical analysis. The relationship between 24 kinds of mineral components and cancer risk was analyzed by multiple logistic regression analysis (JMP6; SAS Institute). The results are shown in Table 1.
この多重ロジスティック回帰分析における決定係数(R2)は0.465であった。尚、表1中、(Part.coeff.)及び(Corr.coeff.)は、夫々、多重ロジスティック回帰分析による部分相関係数及び単回帰分析における相関係数を示す(*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001)。 The coefficient of determination (R 2 ) in this multiple logistic regression analysis was 0.465. In Table 1, (Part.coeff.) And (Corr.coeff.) Indicate a partial correlation coefficient by multiple logistic regression analysis and a correlation coefficient in single regression analysis, respectively (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
更に、毛髪中の濃度と癌リスクとの間に正の相関が見られた代表的な3種類のミネラル(ヨウ素、ヒ素、亜鉛)、及び、負の相関傾向が見られたセレンに関して、ロジスティック回帰分析の結果、受診者動作特性(Receiver Operating Characteristic: ROC)曲線とAUC、及び、その他の各種統計値を図1〜図4に示す。 In addition, logistic regression for three typical minerals (iodine, arsenic, zinc) with positive correlation between hair concentration and cancer risk, and selenium with negative correlation trend. As a result of the analysis, the receiver operating characteristic (Receiver Operating Characteristic: ROC) curve, AUC, and various other statistical values are shown in FIGS.
更に、性別、年齢、及び、有害及び必須ミネラル(計8種類)の濃度を独立変数とする、以下の式(1)を用いて得られた多重直線回帰の値と癌リスクとの相関を多重ロジスティック回帰分析により求めた(R2 = 0.437, r = 0.661, p<0.0001)。更に、受診者動作特性(Receiver Operating Characteristic: ROC)曲線の下の領域の面積(AUC)は0.918であった。これらの結果を図5に示す。 Furthermore, the correlation between cancer risk and multiple linear regression values obtained using the following equation (1), with gender, age, and concentrations of harmful and essential minerals (total 8 types) as independent variables. It was determined by logistic regression analysis (R 2 = 0.437, r = 0.661, p <0.0001). Furthermore, the area (AUC) of the area under the Receiver Operating Characteristic (ROC) curve was 0.918. These results are shown in FIG.
(式1)
多重直線回帰(値)=+0.70 (男性の場合:(+)、女性の場合(−)) + 0.023 x年齢+1.75 x LogI+3.59 x LogAs++5.38 x LogZn+6.67 x LogFe+2.04 x LogNa−6.47 x LogSe−1.48 x LogK−1.47 x LogMn−50.88
(Formula 1)
Multiple linear regression (value) = + 0.70 (for men: (+), for women (-)) + 0.023 x age + 1.75 x LogI + 3.59 x LogAs + + 5.38 x LogZn + 6.67 x LogFe + 2.04 x LogNa −6.47 x LogSe−1.48 x LogK−1.47 x LogMn−50.88
更に、表2に示すような分割表(図5における癌の確率(縦軸)が「0.50」となるときの式1の値(横軸)をカットオフ値として使用)を用いた解析、及びχ2検定により、感度(sensitivity):87.1 %, 特異度(specificity):79.1 %、及び、正確度(accuracy): 83.8 % (108+68)/210、χ2=99.1、p=0.0001)であることが示された。 Further, analysis using a contingency table as shown in Table 2 (using the value of Formula 1 (horizontal axis) when the cancer probability (vertical axis) in FIG. 5 is “0.50” as the cutoff value), and According to χ 2 test, sensitivity: 87.1%, specificity: 79.1%, and accuracy: 83.8% (108 + 68) / 210, χ 2 = 99.1, p = 0.0001) It was shown that there is.
以上の結果が示すように、式1で定義したような、複数の微量ミネラル成分の多重直線回帰の値と癌リスクとの間には極めて有意な相関があることが認められた。
As shown by the above results, it was confirmed that there was a very significant correlation between the value of multiple linear regression of a plurality of trace mineral components as defined by
本発明の検出方法を用いて、極めて非侵襲的な手段によって、癌、特に固形癌を高い精度(正確度)で検出することが可能となり、癌を発見・診断し、又は、癌患者をスクリーニングする方法が提供される。 Using the detection method of the present invention, it becomes possible to detect cancer, particularly solid cancer, with high accuracy (accuracy) by extremely non-invasive means, to detect and diagnose cancer, or to screen cancer patients. A method is provided.
Claims (9)
多重直線回帰(値)=+0.70 (男性の場合:(+)、女性の場合(−)) + 0.023 x 年齢+1.75 x LogI+3.59 x LogAs++5.38 x LogZn+6.67 x LogFe+2.04 x LogNa−6.47 x LogSe−1.48 x LogK−1.47 x LogMn−50.88
を用いる、請求項1〜7のいずれか一項に記載の方法。 The following equation (1) for multiple linear regression:
Multiple linear regression (value) = + 0.70 (for men: (+), for women (-)) + 0.023 x age + 1.75 x LogI + 3.59 x LogAs + + 5.38 x LogZn + 6.67 x LogFe + 2.04 x LogNa −6.47 x LogSe−1.48 x LogK−1.47 x LogMn−50.88
The method according to any one of claims 1 to 7, wherein
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009194688A JP2011047715A (en) | 2009-08-25 | 2009-08-25 | Method for detecting cancer based on comprehensive analysis of mineral components in hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009194688A JP2011047715A (en) | 2009-08-25 | 2009-08-25 | Method for detecting cancer based on comprehensive analysis of mineral components in hair |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2011047715A true JP2011047715A (en) | 2011-03-10 |
Family
ID=43834205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009194688A Pending JP2011047715A (en) | 2009-08-25 | 2009-08-25 | Method for detecting cancer based on comprehensive analysis of mineral components in hair |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2011047715A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013221866A (en) * | 2012-04-17 | 2013-10-28 | Hyogo Science And Technology Association | Method for analyzing concentration of element contained in living matter |
WO2016042805A1 (en) * | 2014-09-15 | 2016-03-24 | 株式会社レナテック | Cancer evaluation method and cancer evaluation system |
KR101746397B1 (en) | 2017-02-20 | 2017-06-13 | 대한민국 | Method for monitoring of metabolic disease or stress, and monitoring device using the same |
WO2019065854A1 (en) * | 2017-09-27 | 2019-04-04 | 株式会社レナテック | Cancer risk evaluation method and cancer risk evaluation system |
PL423375A1 (en) * | 2017-11-07 | 2019-05-20 | Read Gene Spolka Akcyjna | Method for detection of decreased risk of cancers in women who are carriers of a mutation in BRCA1 gene |
-
2009
- 2009-08-25 JP JP2009194688A patent/JP2011047715A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013221866A (en) * | 2012-04-17 | 2013-10-28 | Hyogo Science And Technology Association | Method for analyzing concentration of element contained in living matter |
WO2016042805A1 (en) * | 2014-09-15 | 2016-03-24 | 株式会社レナテック | Cancer evaluation method and cancer evaluation system |
JP6082478B2 (en) * | 2014-09-15 | 2017-02-15 | 株式会社レナテック | Cancer evaluation method and cancer evaluation system |
KR20170054384A (en) * | 2014-09-15 | 2017-05-17 | 가부시키가이샤 레나텟쿠 | Cancer evaluation method and cancer evaluation system |
US10845372B2 (en) | 2014-09-15 | 2020-11-24 | Renatech Co., Ltd. | Cancer evaluation method and cancer evaluation system |
KR102305151B1 (en) | 2014-09-15 | 2021-09-27 | 가부시키가이샤 레나텟쿠 | Cancer evaluation method and cancer evaluation system |
KR101746397B1 (en) | 2017-02-20 | 2017-06-13 | 대한민국 | Method for monitoring of metabolic disease or stress, and monitoring device using the same |
WO2019065854A1 (en) * | 2017-09-27 | 2019-04-04 | 株式会社レナテック | Cancer risk evaluation method and cancer risk evaluation system |
KR20200070267A (en) * | 2017-09-27 | 2020-06-17 | 가부시키가이샤 레나텟쿠 | Cancer risk assessment method and cancer risk assessment system |
KR102635700B1 (en) | 2017-09-27 | 2024-02-14 | 가부시키가이샤 레나텟쿠 | Cancer risk assessment method and cancer risk assessment system |
PL423375A1 (en) * | 2017-11-07 | 2019-05-20 | Read Gene Spolka Akcyjna | Method for detection of decreased risk of cancers in women who are carriers of a mutation in BRCA1 gene |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Henderson et al. | The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis | |
Yang et al. | Placental transfer of perfluoroalkyl substances and associations with thyroid hormones: Beijing prenatal exposure study | |
Meeker et al. | Urinary concentrations of parabens and serum hormone levels, semen quality parameters, and sperm DNA damage | |
He | Trace elements in nails as biomarkers in clinical research | |
Wang et al. | Rare earth elements and hypertension risk among housewives: a pilot study in Shanxi Province, China | |
JP2011047715A (en) | Method for detecting cancer based on comprehensive analysis of mineral components in hair | |
Caciari et al. | Cadmium and hypertension in exposed workers: A meta-analysis | |
Kosanovic et al. | Quantitative analysis of toxic and essential elements in human hair. Clinical validity of results | |
JP5372304B1 (en) | In vivo element testing method | |
Lin et al. | Calibration set selection method based on the “M+ N” theory: application to non-invasive measurement by dynamic spectrum | |
CN103901015B (en) | A kind of detection method that thiocyanate radical in dairy products and melamine are carried out common inspection | |
BR112014005651A2 (en) | diagnostic apparatus | |
Geer et al. | Assessment of prenatal mercury exposure in a predominately Caribbean immigrant community in Brooklyn, NY | |
KR102635700B1 (en) | Cancer risk assessment method and cancer risk assessment system | |
Kaewseekhao et al. | Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy | |
Cai | Determination of select trace elements in hair of college students in Jinzhou, China | |
Adugna et al. | Diagnostic performance of Mini Parasep® solvent-free faecal parasite concentrator relative to Kato-Katz and McMaster for the diagnosis of intestinal parasitic infections | |
Zaichick et al. | Dietary intake of minerals and prostate cancer: insights into problem based on the chemical element contents in the prostate gland | |
WO2016042805A1 (en) | Cancer evaluation method and cancer evaluation system | |
JP2018163174A (en) | Data acquiring and determining method for determining possibility that endometriosis ovarian cyst cancerates | |
Hua et al. | Volatile metabonomic profiling in urine to detect novel biomarkers for B‑cell non‑Hodgkin's lymphoma | |
Ergün et al. | The relation between the extent of radiological findings and respiratory functions in pneumoconiosis cases of dental technicians who are working in Ankara. | |
Mutalik et al. | Oral leukoplakia–Is biopsy at the initial appointment a must? | |
Verma et al. | Dust content of lungs and its relationships to pathology, radiology and occupational exposure in Ontario hardrock miners | |
WO2020059401A1 (en) | Method for examining biological solution |